Top Markets
Coin of the day
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Classement en actions #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Prix de l'action
$1.84
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$3.51M
Changement (1 jour)
0.46%
Changement (1 an)
-62.71%
Pays
US
Échange Dogwood Therapeutics, Inc. (DWTX)

Catégorie

Historique du prix de l'action pour Dogwood Therapeutics, Inc. (DWTX)
Prix de clôture le plus élevé : $1.81 le 2026-08-01

Prix de clôture le plus bas : $241.05 le 2020-12-01
Historique du prix de l'action de Dogwood Therapeutics, Inc. de 2020 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -37.58%
2025 122.27%
2024 -84.09%
2023 144.93%
2022 -94.85%
2021 -47.68%
2020 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE